Table 4.

Basal clinical data of papillary thyroid carcinoma patients with lymph node metastasis.

	PTC	PTC with lymph node metastasis	PTC without lymph node metastasis	p
Age (years)	47.60±1.63	41.64±2.68	48.43±1.92	0.038
Gender (male)	25 (41.7%)	14 (56.0%)	11 (31.4%)	0.057
BMI	24.61±0.40	25.16±0.64	24.22±0.51	0.255
Systolic blood pressure (mmHg)	122.20±1.96	122.68±3.49	118.43±2.26	0.289
Diastolic pressure (mmHg)	77.43±1.28	77.52±1.83	77.37±1.78	0.955
TRAb (IU/ml)	0.30 (0.30, 0.42)	0.30 (0.30, 0.43)	0.30 (0.30, 0.40)	0.835
TSH (μIU/ml)	1.91±0.10	2.16±0.13	1.73±0.13	0.025
T3 (nmol/l)	1.75±0.04	1.87±0.06	1.66±0.04	0.007
T4 (nmol/l)	94.01±1.82	95.67±2.81	92.81±2.40	0.440
FT3 (pmol/l)	4.86±0.07	5.05±0.11	4.73±0.09	0.027
FT4 (pmol/l)	15.92±0.30	16.30±0.44	15.65±0.40	0.285
TGAb (IU/ml)	10.00 (10.00, 11.79)	10.00 (10.00, 11.85)	10.00 (10.00, 12.42)	0.943
TPOAb (IU/ml)	11.35 (8.58, 14.54)	12.97 (10.34, 16.04)	9.27 (6.60, 12.09)	0.595
Parathyroid hormone (pg/ml)	42.49±2.33	40.87±3.04	43.74±3.44	0.547
Alanine transaminase (U/L)	21.00 (15.00, 28.00)	22.50 (14.25, 28.25)	21.00 (13.50, 37.00)	0.088
Glutaminase (U/L)	25.00 (19.00, 29.00)	22.00 (18.00, 33.50)	27.00 (18.00, 28.50)	0.384
Urea (mmol/l)	4.81±0.15	4.60±0.19	4.95±0.23	0.274
Creatinine (μmol/l)	52.00 (46.00, 64.00)	57.00 (45.00, 65.25)	47.00 (45.00, 65.00)	0.179
Uric acid (μmol/l)	332.34±12.31	364.60±17.43	308.62±16.11	0.023
Blood glucose (mmol/l)	5.03 (4.76, 5.43)	5.19 (4.78, 6.78)	4.98 (4.34, 5.16)	0.942
Total cholesterol (mmol/l)	4.61±0.16	4.28±0.20	4.97±0.20	0.027
Triglycerides (mmol/l)	1.28 (1.14, 1.59)	1.22 (1.07, 1.64)	1.28 (1.21, 1.79)	0.549
High density lipoprotein (mmol/l)	1.20 (1.06, 1.42)	1.18 (1.03, 1.49)	1.21 (1.06, 1.49)	0.720
Low density lipoprotein (mmol/l)	2.53±0.11	2.31±0.14	2.79±0.12	0.021

PTC, papillary thyroid carcinoma; BMI, body weight index; TRAb, thyrotropin receptor antibody; TSH, thyrotropin; TGAb, anti-thyroglobulin antibody; TPOAb, thyroid peroxidase antibody. p, comparison between PTC group and NG group.